TY  - GEN
AU  - Martinez-Majander,N
AU  - Ntaios,G
AU  - Liu,Y Y
AU  - Ylikotila,P
AU  - Joensuu,H
AU  - Saarinen,J
AU  - Perera,K S
AU  - Marti-Fabregas,J
AU  - Chamorro,A
AU  - Rudilosso,S
AU  - Prats-Sanchez,L
AU  - Berkowitz,S D
AU  - Mundl,H
AU  - Themeles,E
AU  - Tiainen,M
AU  - Demchuk,A
AU  - Kasner,S E
AU  - Hart,R G
AU  - Tatlisumak,T
TI  - Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial
SN  - 1468-1331
PY  - 2021///0621
KW  - Aspirin
KW  - therapeutic use
KW  - Brain Ischemia
KW  - complications
KW  - Double-Blind Method
KW  - Factor Xa Inhibitors
KW  - Humans
KW  - Intracranial Embolism
KW  - Ischemic Stroke
KW  - Neoplasms
KW  - Platelet Aggregation Inhibitors
KW  - adverse effects
KW  - Rivaroxaban
KW  - Secondary Prevention
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/ene.14172
ER  -